High hyperdiploid (51-67 chromosomes) acute lymphoblastic leukemia (ALL) is one of the most common childhood malignancies, comprising 30% of all pediatric B cell-precursor ALL. Its characteristic genetic feature is the nonrandom gain of chromosomes X, 4, 6, 10, 14, 17, 18 and 21, with individual trisomies or tetrasomies being seen in over 75% of cases, but the pathogenesis remains poorly understood. We performed whole-genome sequencing (WGS) (n = 16) and/or whole-exome sequencing (WES) (n = 39) of diagnostic and remission samples from 51 cases of high hyperdiploid ALL to further define the genomic landscape of this malignancy. The majority of cases showed involvement of the RTK-RAS pathway and of histone modifiers. No recurrent fusion gene-forming rearrangement was found, and an analysis of mutations on trisomic chromosomes indicated that the chromosomal gains were early events, strengthening the notion that the high hyperdiploid pattern is the main driver event in this common pediatric malignancy.
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The mean coverage of the WGS and WES analyses of the 51 cases was 103× and 123×, respectively (Supplementary Tables 1-3 ). The median chromosome number, on the basis of copy number analysis of data obtained from sequence coverage, was 55-56, and 8 of 16 cases (50%) investigated by WGS harbored 1-4 whole-chromosome uniparental disomies (UPDs) ( Fig. 1 and Supplementary Fig. 1) ; these findings agree well with previous data on the chromosomal content of high hyperdiploid childhood ALL 1 . Subclonal gains of one or two whole chromosomes were seen in four cases, including trisomy/ tetrasomy 18 (2:2 allelic ratio) in case 10, trisomy/tetrasomy 21 (3:1 allelic ratio) in case 11, disomy/trisomy 4 in case 13, and UPD/ trisomy 16 and disomy/monosomy 13 in case 14. Furthermore, subclonality was detected for the majority of structural aberrations leading to copy number changes, including four of four cases with dup(1q), one of one idic(7)(p11) and one of one idic(17)(p11.2).
The mean and median number of somatic mutations in cases analyzed with WGS, including single-nucleotide variants (SNVs), insertions and deletions (indels), and substitutions involving more than one nucleotide, were 1,292 and 801 (range of 123-7,862), respectively. The corresponding numbers for mutations in coding regions, excluding synonymous variants, were 7.5 and 6 (range of 0-5), respectively, for all 51 cases (Supplementary Tables 4 and 5). There was no correlation between the total number of mutations or of coding mutations and modal chromosome number, sex or white blood cell count. However, the total number of mutations was significantly higher in older patients (mean of 425 (range of 123-703) in those aged 1-3 years versus mean of 1,812 (range of 678-7,862) in those aged >3 years; P = 0.029), as was the number of coding mutations (mean of 3.6 (range of 0-9) versus mean of 11 (range of 1-55); P < 0.0001). This difference probably reflects the higher number of cell divisions that the leukemia-initiating cell has gone through in older patients; similar increases in mutation frequency with age have previously been observed in pediatric neuroblastoma and T cell ALL 2, 3 . The four cases who relapsed had on average 5.5 mutations in coding regions, as compared with the 7.7 mutations identified in those who did not relapse (Supplementary Table 1) .
Analysis of the genomic context of SNVs in coding regions for all cases except case 12 (discussed below) showed that the majority (274/415; 66%) were C>T transitions, most of which involved CpG dinucleotides (188/274; 69%; Fig. 2 ). This is the most common mutational signature in the human genome and is a sign of endogenous mutagenic mechanisms, that is, deamination of 5-methylcytosine to thymidine 4, 5 . In contrast to what was recently reported for ETV6-RUNX1-positive childhood ALL 6 , we did not detect a signature corresponding to transitions and transversions at cytosines in TpC dinucleotides, which would have indicated an involvement of the APOBEC family of enzymes. Thus, in spite of the clinical similarities between high hyperdiploid and ETV6-RUNX1-positive childhood ALL, such as favorable outcome, prenatal origin and age peak, their mutational signatures differ, indicating different etiologic and pathogenetic mechanisms. Case 12 harbored the highest number of both total (n = 7,862) and nonsynonymous coding (n = 55) mutations in the investigated cohort. Notably, this case also displayed a different mutational pattern, with 77 of 89 (87%) of the mutations in coding regions (silent and nonsilent) being C>T transitions; of these, only trafficking events 8 , but it is rarely expressed in high hyperdiploid childhood ALL 9 . No RNA was available from case 2, precluding identification of an upregulated gene at 19q13. Case 16 had a 40-kb deletion in 16q22.1 that resulted in an in-frame fusion between exon 5 of CTCF and exon 2 of PARD6A; this fusion was validated by RNA-seq and RT-PCR ( Supplementary Fig. 4 and Supplementary Table 11 ). PARD6A regulates centrosomal protein recruitment and cytokinesis 10 , whereas CTCF is a regulator of higher-order chromatin structure 11 . The 16q22 deletion in case 16 leads to complete loss of zinc fingers 5-11 in CTCF. Zinc fingers 4-7 bind to the core motif of CTCF genomic target sites 12 , and it may thus be surmised that the CTCF-PARD6A fusion severely affects the normal function of CTCF. Case 16 also harbored an interstitial deletion on Xp leading to a P2RY8-CRLF2 fusion, which has previously been reported in childhood ALL 13 . None of the other structural rearrangements 0  140  120  100  80  60  40  20  0  40  20  0  40  20  0  60  40  20   40  20  0  60  40  20  0  80  60  40  20   0  80  60  40  20  0  100  80  60  40  20  0  100  80  60  40  20  0   100  80  60  40  20  0   12 0  10 0  80  60  40  20  0  12  0  10  0  80  60  40  20  0  12 0  10 0  80  60  40  20  0  140  120  100  80  60  40 LGA LS3 SS TR1 TEP 1 36% were at CpGs (Supplementary Fig. 2 ). An investigation of the previously identified regions in the IKZF1, ARID5B and CEBPE genes that have been linked to increased risk of high hyperdiploid childhood ALL did not identify any new constitutional variants predisposing to leukemia development in any of the 51 cases (Supplementary Tables 6-10 and Supplementary Note).
A total of 75 somatic structural joints resulting from translocations, deletions, duplications and complex rearrangements (Supplementary Table 11 ) were detected by WGS. Multiple deletions and duplications involving single genes were seen, including known targets such as ADD3, ETV6, IKZF1 and PAX5, as well as genes not previously implicated (Supplementary Table 11) . There was no evidence of chromothripsis in any of the cases 7 . Two cases had reciprocal translocations involving the IGK locus at 2p11.2: t(2;8)(p11.2;q21.13) in case 15 and t(2;19)(p11.2;q13.32) in case 2. RNA sequencing (RNA-seq) of the breakpoint region on chromosome 8 in case 15 showed high expression of TPD52, located ~400 kb from the breakpoint, as compared with expression in 35 other high hyperdiploid childhood ALLs (Supplementary Fig. 3) . TPD52, which is frequently upregulated in neoplasia, encodes a protein that may have a role in cytokinesis by supporting membrane l e t t e r s npg l e t t e r s identified by WGS (Supplementary Table 11) could be shown to result in expressed fusion genes.
The number of mutations in coding regions correlated with the total number of mutations (Pearson correlation coefficient = 0.975; P < 0.0001), suggesting a random distribution of mutations throughout the genomes and indicating a large number of passenger mutations. A total of 399 SNVs, indels and substitutions in coding regions were detected in the 51 cases; for a subset of these, Sanger sequencing was performed for validation (Online Methods). Nine genes were recurrently mutated and were also either mutated more frequently than expected by chance according to MutSigCV 14 or targeted by structural events. These included six well-known leukemia-associated genes: KRAS (13/51 cases; 25%), FLT3 (6/51 cases; 12%), CREBBP (5/51 cases; 9.8%), NRAS (5/51 cases; 9.8%), WHSC1 (3/51 cases; 5.9%) and PTPN11 (3/51 cases; 5.9%), of which CREBBP and WHSC1 were also targeted by small deletions in one case each (Supplementary Tables 4, 5  and 11) . The mutated alleles of the above-mentioned genes were all expressed, except one with a frameshift insertion in CREBBP, in cases with available RNA-seq data (Supplementary Tables 4 and 5) . In total, mutations in the receptor tyrosine kinase (RTK)-RAS signaling pathway, including in the FLT3, NRAS, KRAS and PTPN11 genes, were seen in 26 of 51 cases (51%) (Fig. 3 and Supplementary Tables 4 and 5) , a frequency notably higher than the ~30% previously suggested [15] [16] [17] [18] .
In addition to eight KRAS mutations in the known codon 12 and 13 hotspot region, there were three mutations encoding p.Lys117Asn and two mutations encoding p.Ala146Thr (Supplementary Tables 4  and 5) ; both of these substitutions have been reported in colorectal cancer and have been shown to lead to downstream phosphorylation of extracellular signal-regulated kinase (ERK) 19 . p.Lys117Asn has also been identified in a single case of high hyperdiploid childhood ALL at relapse 20 , and p.Ala146Thr has been shown to occur in other types of hematologic malignancies 21, 22 , including two cases of nonhyperdiploid childhood ALL 23 . Thus, KRAS codons 117 and 146 may be new recurrent mutational hotspots in high hyperdiploid ALL. Other genes frequently targeted by mutations were those encoding histone modifiers, including CREBBP in six cases (12%), WHSC1 in four cases (7.8%) and SUV420H1, SETD2 and EZH2 in one case each (2.0% ; Fig. 3) ; in total, 12 of 51 (24%) cases harbored mutations or deletions in one of these genes. CREBBP has been reported to be mutated in a high proportion of relapsing high hyperdiploid childhood ALLs 24 ; however, none of the six cases with a CREBBP mutation or deletion has relapsed (Supplementary Table 1 ). The mutations in the remaining three genes that were identified as possible drivers-DPP6 (4/51 cases; 7.8%), MLLT3 (2/51 cases; 3.9%) and PRB2 (2/51 cases; 3.9%)-were not damaging according to Provean and SIFT, have not previously been reported to be mutated in ALL and were not expressed according to RNA-seq data (Supplementary Tables 4 and 5); their importance is hence unclear.
To investigate how early in the leukemogenic process the chromosomal gains occurred, we compared the number of somatic mutations present on one of the three copies of trisomic chromosomes with the number of mutations present on two of the three copies in each case subjected to WGS (Fig. 4 and Supplementary Figs. 5 and 6) . Whereas mutations present on one of three homologs could have occurred either before or after the chromosomal gain, mutations present on two of three homologs must have preceded the formation of the trisomy (Supplementary Fig. 5 ). On the basis of these data, we calculated the number of mutations occurring before the trisomies (BTRI mutations) and after the trisomies (ATRI mutations). For 14 of 16 (88%) cases, the number of ATRI mutations was much (3-33×) higher than the number of BTRI mutations (Supplementary Table 12) , indicating either a longer time period between trisomy occurrence and diagnosis than between the initial hematopoietic stem cell and the trisomy occurrence or an increased mutation rate after trisomy occurrence. Similar results were obtained when we looked at UPDs in 4 of these 14 cases, identifying a high number of heterozygous mutations; these must have occurred after the UPD. It has been shown that the chromosomal gains in high hyperdiploid ALL, at least sometimes, arise prenatally [25] [26] [27] [28] . Hence, we deem it likely that the high frequency of mutations occurring after as compared with before the trisomy indicates a long latency period after the high hyperdiploid pattern was established in most patients. Two cases displayed an equal or Table 12 ). These were the two oldest patients in the cohort-both were 13 years old-suggesting that the etiology of high hyperdiploid childhood ALL may differ in older patients.
To ascertain whether high hyperdiploidy is associated with gene dosage effects, we investigated the association between copy number changes identified on the basis of SNP array analysis and gene expression in a cohort of 29 high hyperdiploid cases with available RNA-seq data. There was a clear correlation between gene copy number and expression levels (Supplementary Fig. 7 ), agreeing well with previous studies reporting increased expression of genes on the gained chromosomes in high hyperdiploid childhood ALL [29] [30] [31] and indicating that the chromosomal gains result in gene dosage effects.
Considering the absence of a recurrent fusion gene or common mutation and the present evidence that chromosomal gains are early events, we conclude that the initiating pathogenetic step in the leukemogenesis of high hyperdiploid childhood ALL is the high hyperdiploid pattern in itself. It is noteworthy that several cases in our study harbored changes involving centrosome-related proteins, such as mutations of CEP290, NRK and AKAP9 and deletion of CEP76 and CEP192 (Supplementary Tables 4, 5 and 11) , which could have promoted abnormal cell division. However, as none of these genes was recurrently targeted, their impact remains unclear. The consequence of the chromosomal gains is probably dosage effects ( Supplementary  Fig. 7 ), but additional genetic aberrations are most likely needed for overt leukemia. Our results suggest that, although these secondary hits are heterogeneous in high hyperdiploid childhood ALL, mutations targeting the RTK-RAS pathway and histone modifiers are particularly common. Therefore, these could be attractive targets for new therapies in high hyperdiploid pediatric ALL. 
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